Recurrent nodular regenerative hyperplasia post‐liver transplantation in common variable immunodeficiency

Liver involvement is well described in common variable immunodeficiency (CVID) and is an important prognostic marker. While multiple etiologies for liver disease have been reported, nodular regenerative hyperplasia (NRH) is being increasingly recognized with an overall prevalence above 5% (1). In this case series we describe the pre and post-transplant evolution of CVID-related liver disease (CVID-ld). (Table 1.).